BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27443953)

  • 21. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
    Sing T; Jinnin M; Yamane K; Honda N; Makino K; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
    Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β-mediated upregulation of brachyury contributes to constitutively up-regulated type I collagen expression in skin fibroblasts: possible role in systemic sclerosis.
    Teng L; Yao G; Gao R; Wang Y; Lin W; Jin Y; Wang Y; Chen H; Wang Z; Chen J
    Eur J Dermatol; 2019 Aug; 29(4):359-365. PubMed ID: 31625918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
    Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
    Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
    Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.
    Saigusa R; Asano Y; Taniguchi T; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    Exp Dermatol; 2015 Feb; 24(2):127-32. PubMed ID: 25421497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.
    Kudo H; Jinnin M; Asano Y; Trojanowska M; Nakayama W; Inoue K; Honda N; Kajihara I; Makino K; Fukushima S; Ihn H
    Arthritis Rheumatol; 2014 Jun; 66(6):1636-47. PubMed ID: 24470401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis.
    Bhandari R; Yang H; Kosarek NN; Smith AE; Garlick JA; Hinchcliff M; Whitfield ML; Pioli PA
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI114-SI124. PubMed ID: 35946522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research on feasibility of in vitro inflammatory wound microenvironment simulated by using inflammatory wound tissue homogenate of mice].
    Hao Y; Yang QX; Wang Q; Xu GC; Qi F; Deng CL; Wei ZR; Wang DL
    Zhonghua Shao Shang Za Zhi; 2020 Nov; 36(11):1024-1034. PubMed ID: 33238685
    [No Abstract]   [Full Text] [Related]  

  • 31. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
    Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
    J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma.
    Makino K; Jinnin M; Hirano A; Yamane K; Eto M; Kusano T; Honda N; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
    J Immunol; 2013 Apr; 190(8):3905-15. PubMed ID: 23509348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
    Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
    J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
    Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
    Santiago B; Galindo M; Rivero M; Pablos JL
    Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
    Dees C; Tomcik M; Zerr P; Akhmetshina A; Horn A; Palumbo K; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Jul; 70(7):1304-10. PubMed ID: 21450749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
    Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.